Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings
The purpose of this notice of funding opportunity is to support research on Long-Acting Injectable-Antiretroviral Therapy (LAI-ART) by implementing LAI-ART administration in both clinic and non-clinic settings (e.g., community pharmacies).
A multi-site effectiveness-implementation research study designed to compare receiving LAI-ART in clinic or pharmacy settings with the oral standard-of-care for the treatment of HIV will offer a unique source of information for improving acceptability, availability, and uptake of LAI-ART.
Implementation outcomes of interest include acceptability, perceived barriers and facilitators, feasibility, and sustainability.
Health outcomes of interest include missed visits, on-time receipt of injections, and the HIV care continuum, including retention in care and viral load suppression.
The data collected will describe real-world LAI-ART use among persons with HIV (PWH) in an era of multiple HIV treatment modalities.
Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART.
A multi-site effectiveness-implementation research study designed to compare receiving LAI-ART in clinic or pharmacy settings with the oral standard-of-care for the treatment of HIV will offer a unique source of information for improving acceptability, availability, and uptake of LAI-ART.
Implementation outcomes of interest include acceptability, perceived barriers and facilitators, feasibility, and sustainability.
Health outcomes of interest include missed visits, on-time receipt of injections, and the HIV care continuum, including retention in care and viral load suppression.
The data collected will describe real-world LAI-ART use among persons with HIV (PWH) in an era of multiple HIV treatment modalities.
Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART.
Related Programs
Prevention of Disease, Disability, and Death by Infectious Diseases
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $4,000,000
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $4,000,000
Who's Eligible
Obtain Full Opportunity Text:
Recovery Community Services Program (RCSP) Supplements
Additional Information of Eligibility:
N/A
Full Opportunity Web Address:
http://www.samhsa.gov/grants/2011/ti_11_004.aspx
Contact:
Agency Email Description:
fzp0@cdc.gov
Agency Email:
Date Posted:
2022-12-22
Application Due Date:
Archive Date:
2023-03-29
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
